PMID- 30053467 OWN - NLM STAT- MEDLINE DCOM- 20190830 LR - 20190830 IS - 1879-1891 (Electronic) IS - 0002-9394 (Linking) VI - 194 DP - 2018 Oct TI - Macular Damage, as Determined by Structure-Function Staging, Is Associated With Worse Vision-related Quality of Life in Early Glaucoma. PG - 88-94 LID - S0002-9394(18)30392-1 [pii] LID - 10.1016/j.ajo.2018.07.011 [doi] AB - PURPOSE: Macular damage is common early in glaucoma and has previously been identified as a significant factor affecting vision-related quality of life (VRQoL) across the spectrum of glaucomatous damage. This report uses structure-function correlation to identify early macular damage and assess its relationship with the National Eye Institute Visual Function Questionnaire (NEI VFQ-25). DESIGN: Cohort study. METHODS: Setting: Institutional. STUDY POPULATION: Eighty-eight eyes of 44 participants with early open-angle glaucoma (24-2 mean deviation [MD] better than -6 dB). OBSERVATION PROCEDURE: Focal and diffuse macular defects were identified based on corresponding abnormal regions on probability maps from spectral-domain optical coherence tomography (SD-OCT) optic disc and macular cube scans, and 10-2 and 24-2 visual fields (VF). MAIN OUTCOME MEASURE: VRQoL, as measured by the NEI VFQ-25. RESULTS: Twenty-five of 44 (57%) "worse" eyes (defined by 24-2 VF MD) and 13 of 44 (31%) "better" eyes had macular damage. Mean (+/-standard deviation) MD of worse and better eyes were -3.03 dB (+/-2.3) and -1.15 dB (+/-1.7), respectively. Compared to those without macular damage, lower NEI VFQ-25 scores were seen in patients with macular damage in the worse eye (85.4 [+/- 9.0] vs 94.6 [+/- 3.3]; P = .0001) and the better eye (84.8 [+/- 11.1] vs 91.3 [+/- 6.3]; P = .017). Arcuate damage outside the macula did not affect VRQoL (better eye, P = .40; worse eye, P = .87). CONCLUSIONS: Early glaucomatous macular damage, as detected by abnormal topographic regions on measures of structure and function, is associated with decreased VRQoL. Arcuate damage outside the macula does not have an association with VRQoL in early glaucoma. CI - Copyright (c) 2018 Elsevier Inc. All rights reserved. FAU - Garg, Aakriti AU - Garg A AD - Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University Medical Center, New York, New York, USA. FAU - Hood, Donald C AU - Hood DC AD - Departments of Psychology and Ophthalmology, Columbia University, New York, New York, USA. FAU - Pensec, Noelle AU - Pensec N AD - Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University Medical Center, New York, New York, USA. FAU - Liebmann, Jeffrey M AU - Liebmann JM AD - Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University Medical Center, New York, New York, USA. FAU - Blumberg, Dana M AU - Blumberg DM AD - Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Department of Ophthalmology, Columbia University Medical Center, New York, New York, USA. Electronic address: dmb2196@columbia.edu. LA - eng GR - R01 EY002115/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20180725 PL - United States TA - Am J Ophthalmol JT - American journal of ophthalmology JID - 0370500 SB - IM MH - Aged MH - Cohort Studies MH - Female MH - Glaucoma, Open-Angle/*diagnosis/psychology MH - Gonioscopy MH - Humans MH - Intraocular Pressure/physiology MH - Macula Lutea/*pathology MH - Male MH - Middle Aged MH - Ophthalmoscopy MH - Prospective Studies MH - Quality of Life/*psychology MH - Retinal Diseases/*diagnosis/psychology MH - Sensitivity and Specificity MH - *Sickness Impact Profile MH - Slit Lamp Microscopy MH - Surveys and Questionnaires MH - Tomography, Optical Coherence/methods MH - Vision Disorders/*diagnosis/psychology MH - Visual Acuity/physiology MH - Visual Field Tests EDAT- 2018/07/28 06:00 MHDA- 2019/08/31 06:00 CRDT- 2018/07/28 06:00 PHST- 2018/05/07 00:00 [received] PHST- 2018/07/08 00:00 [revised] PHST- 2018/07/11 00:00 [accepted] PHST- 2018/07/28 06:00 [pubmed] PHST- 2019/08/31 06:00 [medline] PHST- 2018/07/28 06:00 [entrez] AID - S0002-9394(18)30392-1 [pii] AID - 10.1016/j.ajo.2018.07.011 [doi] PST - ppublish SO - Am J Ophthalmol. 2018 Oct;194:88-94. doi: 10.1016/j.ajo.2018.07.011. Epub 2018 Jul 25.